Results 81 to 90 of about 21,939 (156)

Case Report: Heterotopic Pancreatic Tissue Leading to Acute on Chronic Cholecystitis. [PDF]

open access: yesCureus, 2023
Tekin YB   +4 more
europepmc   +1 more source

The Evolution of Medications for Obesity Management

open access: yesJGH Open, Volume 10, Issue 9, September 2026.
ABSTRACT This narrative review provides an overview of progress in the development of obesity medications, including a synthesis of data describing the efficacy and safety of currently available agents and emerging therapeutic options. Historically, many obesity medications have been withdrawn from the market due to safety concerns.
Jaskirath Gill, Priya Sumithran
wiley   +1 more source

Diagnostic Guidelines for the Evaluation of Choledocholithiasis in Patients With Acute Biliary Presentations: A Study of Their Applicability and Feasibility in a Publicly Funded Healthcare System

open access: yesANZ Journal of Surgery, Volume 96, Issue 9, Page 2522-2530, September 2026.
ABSTRACT Background The American and European Societies of Gastrointestinal Endoscopy (ASGE and ESGE) have published diagnostic guidelines for the evaluation of choledocholithiasis. The applicability and feasibility of these guidelines in a publicly funded health care system, such as ours in Aotearoa New Zealand, are not known. This retrospective study
Henry C. K. Kwok   +3 more
wiley   +1 more source

Endoscopic Papillectomy May Be a Feasible Treatment Option for Elderly Patients With Ampullary Tumors: A Multicenter Retrospective Study

open access: yesDigestive Endoscopy, Volume 38, Issue 9, September 2026.
Multicenter retrospective analysis of 255 patients undergoing endoscopic papillectomy demonstrated significantly lower rates of delayed bleeding and post‐EP pancreatitis in patients aged ≥ 75 years. Age ≥ 75 75 years was independently associated with reduced risks of both adverse events, while serious complications, complete resection, and recurrence ...
Noriki Kasuga   +12 more
wiley   +1 more source

Landscape in the gallbladder mycobiome and bacteriome of patients undergoing cholelithiasis with chronic cholecystitis. [PDF]

open access: yesFront Microbiol, 2023
Hu J   +8 more
europepmc   +1 more source

Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8347-8358, September 2026.
ABSTRACT Aims Orforglipron is a novel small‐molecule, once daily oral non‐peptide GLP‐1 receptor agonist. The hepatic safety profile in adults with obesity or overweight and/or type 2 diabetes (T2D) across seven orforglipron Phase 3 clinical trials was assessed.
Sean Wharton   +5 more
wiley   +1 more source

Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early‐Phase Clinical Trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue S5, Page 42-50, September 2026.
ABSTRACT Aims The management of the disease of obesity has been transformed by incretin‐based therapies; however, additional and alternative therapeutic strategies are needed to address its biological complexity. This narrative review examines the physiology of amylin and the emerging role of amylin‐based therapies in obesity management.
Abdulhameed Alhazmi, Carel W. le Roux
wiley   +1 more source

Home - About - Disclaimer - Privacy